Unlicensed “Special” Medicines: Understanding the Community Pharmacist Perspective

Alesha Wale,1 Mark Ireland,2 Rowan Yemm,1 Sarah Hiom,3 Alison Jones,3 John Paul Spark,3 Mark Francis,4 Karen May,5 Louise Allen,5 Steve Ridd,6 Efi Mantzourani1,7 1School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, Wales, UK; 2Community Pharmacy Wales, Cardiff, Wales, UK; 3S...

Full description

Bibliographic Details
Main Authors: Wale A, Ireland M, Yemm R, Hiom S, Jones A, Spark JP, Francis M, May K, Allen L, Ridd S, Mantzourani E
Format: Article
Language:English
Published: Dove Medical Press 2020-08-01
Series:Integrated Pharmacy Research and Practice
Subjects:
Online Access:https://www.dovepress.com/unlicensed-ldquospecialrdquo-medicines-understanding-the-community-pha-peer-reviewed-article-IPRP
id doaj-9279d0af988a4555bb090c45e8ad9348
record_format Article
spelling doaj-9279d0af988a4555bb090c45e8ad93482020-11-25T02:42:30ZengDove Medical PressIntegrated Pharmacy Research and Practice2230-52542020-08-01Volume 99310456232Unlicensed “Special” Medicines: Understanding the Community Pharmacist PerspectiveWale AIreland MYemm RHiom SJones ASpark JPFrancis MMay KAllen LRidd SMantzourani EAlesha Wale,1 Mark Ireland,2 Rowan Yemm,1 Sarah Hiom,3 Alison Jones,3 John Paul Spark,3 Mark Francis,4 Karen May,5 Louise Allen,5 Steve Ridd,6 Efi Mantzourani1,7 1School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, Wales, UK; 2Community Pharmacy Wales, Cardiff, Wales, UK; 3St. Mary’s Pharmaceutical Unit, Cardiff, Wales, UK; 4Swansea Bay University Health Board, Swansea, Wales, UK; 5Cardiff and Vale University Health Board, Swansea, Wales, UK; 6Mayberry Pharmacy, Cardiff, Wales, UK; 7NHS Wales Informatics Service, Cardiff, Wales, UKCorrespondence: Efi Mantzourani Email MantzouraniE1@cardiff.ac.ukObjective: Community pharmacy staff are responsible for obtaining and supplying unlicensed “special” medicines to patients in primary care. Less well-defined parameters for safe and effective use of unlicensed compared to licensed medicines, along with issues around maintaining consistency between care settings or among manufacturers, have been associated with increased risks. This study aimed to explore the views and experiences of community pharmacy staff on accessing and supplying unlicensed “special” medicines to patients in Wales and the perceived impact of challenges faced on patient care.Methods: A qualitative, phenomenological approach was employed, involving semi-structured interviews with pharmacists and pharmacy technicians working at one small chain of community pharmacies in Wales. The interview schedule focused on the personal experiences and perceptions of the participants on the processes involved in accessing and supplying unlicensed “special” medicines from a community pharmacy. Interviews were audio-recorded and transcribed verbatim.Results: A total of six participants completed the interview. Three main themes were constructed from inductive thematic analysis of the transcribed interviews: requirement for additional patient responsibilities; influences on the confidence felt by pharmacy staff when accessing and supplying unlicensed “special” medicines; and continuity of supply.Conclusion: This study gives a preliminary insight into the views and experiences of community pharmacy staff in Wales when accessing and supplying unlicensed “special” medicines. Further research is required to see if these views and experiences are representative of community pharmacy staff across the country.Keywords: unlicensed medicines, “special” medicines, specials, community pharmacy, transfer of care, medicines supply, transmural care, off-label, compoundinghttps://www.dovepress.com/unlicensed-ldquospecialrdquo-medicines-understanding-the-community-pha-peer-reviewed-article-IPRPunlicensed medicines‘special’ medicinesspecialscommunity pharmacytransfer of caremedicines supplytransmural careoff-labelcompounding.
collection DOAJ
language English
format Article
sources DOAJ
author Wale A
Ireland M
Yemm R
Hiom S
Jones A
Spark JP
Francis M
May K
Allen L
Ridd S
Mantzourani E
spellingShingle Wale A
Ireland M
Yemm R
Hiom S
Jones A
Spark JP
Francis M
May K
Allen L
Ridd S
Mantzourani E
Unlicensed “Special” Medicines: Understanding the Community Pharmacist Perspective
Integrated Pharmacy Research and Practice
unlicensed medicines
‘special’ medicines
specials
community pharmacy
transfer of care
medicines supply
transmural care
off-label
compounding.
author_facet Wale A
Ireland M
Yemm R
Hiom S
Jones A
Spark JP
Francis M
May K
Allen L
Ridd S
Mantzourani E
author_sort Wale A
title Unlicensed “Special” Medicines: Understanding the Community Pharmacist Perspective
title_short Unlicensed “Special” Medicines: Understanding the Community Pharmacist Perspective
title_full Unlicensed “Special” Medicines: Understanding the Community Pharmacist Perspective
title_fullStr Unlicensed “Special” Medicines: Understanding the Community Pharmacist Perspective
title_full_unstemmed Unlicensed “Special” Medicines: Understanding the Community Pharmacist Perspective
title_sort unlicensed “special” medicines: understanding the community pharmacist perspective
publisher Dove Medical Press
series Integrated Pharmacy Research and Practice
issn 2230-5254
publishDate 2020-08-01
description Alesha Wale,1 Mark Ireland,2 Rowan Yemm,1 Sarah Hiom,3 Alison Jones,3 John Paul Spark,3 Mark Francis,4 Karen May,5 Louise Allen,5 Steve Ridd,6 Efi Mantzourani1,7 1School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, Wales, UK; 2Community Pharmacy Wales, Cardiff, Wales, UK; 3St. Mary’s Pharmaceutical Unit, Cardiff, Wales, UK; 4Swansea Bay University Health Board, Swansea, Wales, UK; 5Cardiff and Vale University Health Board, Swansea, Wales, UK; 6Mayberry Pharmacy, Cardiff, Wales, UK; 7NHS Wales Informatics Service, Cardiff, Wales, UKCorrespondence: Efi Mantzourani Email MantzouraniE1@cardiff.ac.ukObjective: Community pharmacy staff are responsible for obtaining and supplying unlicensed “special” medicines to patients in primary care. Less well-defined parameters for safe and effective use of unlicensed compared to licensed medicines, along with issues around maintaining consistency between care settings or among manufacturers, have been associated with increased risks. This study aimed to explore the views and experiences of community pharmacy staff on accessing and supplying unlicensed “special” medicines to patients in Wales and the perceived impact of challenges faced on patient care.Methods: A qualitative, phenomenological approach was employed, involving semi-structured interviews with pharmacists and pharmacy technicians working at one small chain of community pharmacies in Wales. The interview schedule focused on the personal experiences and perceptions of the participants on the processes involved in accessing and supplying unlicensed “special” medicines from a community pharmacy. Interviews were audio-recorded and transcribed verbatim.Results: A total of six participants completed the interview. Three main themes were constructed from inductive thematic analysis of the transcribed interviews: requirement for additional patient responsibilities; influences on the confidence felt by pharmacy staff when accessing and supplying unlicensed “special” medicines; and continuity of supply.Conclusion: This study gives a preliminary insight into the views and experiences of community pharmacy staff in Wales when accessing and supplying unlicensed “special” medicines. Further research is required to see if these views and experiences are representative of community pharmacy staff across the country.Keywords: unlicensed medicines, “special” medicines, specials, community pharmacy, transfer of care, medicines supply, transmural care, off-label, compounding
topic unlicensed medicines
‘special’ medicines
specials
community pharmacy
transfer of care
medicines supply
transmural care
off-label
compounding.
url https://www.dovepress.com/unlicensed-ldquospecialrdquo-medicines-understanding-the-community-pha-peer-reviewed-article-IPRP
work_keys_str_mv AT walea unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective
AT irelandm unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective
AT yemmr unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective
AT hioms unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective
AT jonesa unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective
AT sparkjp unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective
AT francism unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective
AT mayk unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective
AT allenl unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective
AT ridds unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective
AT mantzouranie unlicensedldquospecialrdquomedicinesunderstandingthecommunitypharmacistperspective
_version_ 1724773513670164480